Clinical Research Directory
Browse clinical research sites, groups, and studies.
Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor: Memorial Sloan Kettering Cancer Center
Summary
The purpose of this study is to see if fecal microbiota transplantation (FMT) will prevent the future development of CDI. This is also known as fecal bacteriotherapy or stool transplant.
Official title: A Randomized Controlled Trial of Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
59
Start Date
2014-10
Completion Date
2026-10
Last Updated
2025-11-17
Healthy Volunteers
No
Conditions
Interventions
fecal microbiota transplantation (FMT)
No fecal microbiota transplantation (FMT), routine management
Locations (1)
Memorial Sloan Kettering Cancer Center
New York, New York, United States